摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

asperphenamate | 63631-36-7

中文名称
——
中文别名
——
英文名称
asperphenamate
英文别名
anabellamide;auranamide;[(2S)-2-benzamido-3-phenylpropyl] (2S)-2-benzamido-3-phenylpropanoate
asperphenamate化学式
CAS
63631-36-7
化学式
C32H30N2O4
mdl
——
分子量
506.601
InChiKey
CVULDJMCSSACEO-VMPREFPWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    DMF:可溶; DMSO:可溶;乙醇:可溶;甲醇:可溶

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    38
  • 可旋转键数:
    12
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    84.5
  • 氢给体数:
    2
  • 氢受体数:
    4

制备方法与用途

生物活性

Asperphenamate 是来自 Aspergillus flavipes 的真菌代谢物,具有抗肿瘤活性。其对 T47D、MDA-MB-231 和 HL-60 细胞的 IC50 值分别为 92.3 μM、96.5 μM 和 97.9 μM。

体外研究

Asperphenamate 能通过完全诱导自噬来抑制癌细胞增殖。此外,它对溶酶体蛋白水解酶 cathepsin L 具有抑制作用,同时对 cathepsin S 的抑制能力较弱。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Banerji, Avijit; Ray, Rita, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1981, vol. 20, # 7, p. 597 - 598
    摘要:
    DOI:
  • 作为产物:
    描述:
    (S)-(S)-2-benzamido-3-phenylpropyl 2-(tert-butoxycarbonylamino)-3-phenylpropanoate 在 吡啶盐酸 作用下, 以 乙酸乙酯 为溶剂, 生成 asperphenamate
    参考文献:
    名称:
    Synthesis and in vitro antitumor activity of asperphenamate derivatives as autophagy inducer
    摘要:
    In an effort to improve the aqueous solubility and the antitumor activity of natural product asperphenamate, we have designed and synthesized three series of asperphenamate derivatives, including series I (simplifying molecular skeleton series), series II (introducing a hydroxyl group to A-phenyl ring series) and series III (disrupting molecular planarity series). All derivatives have displayed a significantly increased solubility compared with asperphenamate. Their growth inhibitory activities in vitro were screened by the standard MTT method in MCF-7, HeLa, and BEL-7402 cell lines. With the exception of the derivatives in series I, most of derivatives in series II and series III showed growth inhibitory activity. Among all derivatives, IM23b in series III showed the greatest potency in human breast cancer MCF-7 cells. The cellular potency of IM23b was approximately 1.5-fold more potent than that of cisplatin. The mechanism of cell death induced by IM23b in human breast cancer MCF-7 cells was further investigated. We concluded that the cell death was induced by autophagy instead of apoptosis or cell cycle arrest. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.01.101
点击查看最新优质反应信息

文献信息

  • Asperphenamate biosynthesis reveals a novel two-module NRPS system to synthesize amino acid esters in fungi
    作者:Wei Li、Aili Fan、Long Wang、Peng Zhang、Zhiguo Liu、Zhiqiang An、Wen-Bing Yin
    DOI:10.1039/c7sc02396k
    日期:——
    a group of structurally diverse natural products with distinct activities. Some are synthesized through an inter-molecular esterification step catalysed by nonribosomal peptide synthetase (NRPS). In bacteria, the formation of the intra-molecular ester bond is usually catalysed by a thioesterase domain of NRPS. However, the mechanism by which fungal NRPSs perform this process remains unclear. Herein
    氨基酸酯是一组结构多样、具有独特活性的天然产物。有些是通过非核糖体肽合成酶 (NRPS) 催化的分子间酯化步骤合成的。在细菌中,分子内酯键的形成通常由 NRPS 的硫酯酶结构域催化。然而,真菌 NRPS 执行这一过程的机制仍不清楚。在此,通过短致青霉中的靶向基因破坏和构巢曲霉中的异源表达,我们表明两种NRPS,ApmA和ApmB,足以合成氨基酸酯asperphenamate。使用异源表达系统,我们发现具有还原酶结构域的 ApmA 很少产生二肽醇。相比之下,ApmB 不仅能催化分子间酯键的形成,还能将线性二肽基前体接受到 NRPS 链中。这里描述的机制提供了一种以 NRPS 作为催化剂合成新小分子的方法。我们的研究首次揭示了自然界中氨基酸酯形成的双模块 NRPS 系统。
  • Total synthesis and anticancer activity studies of the stereoisomers of asperphenamate and patriscabratine
    作者:Lei Yuan、Jin Hui Wang、Tie Min Sun
    DOI:10.1016/j.cclet.2009.10.004
    日期:2010.2
    All stereoisomers of asperphenamate 1a and patriscabratine 2a were achieved with a high yield, and total synthesis of 2a is firstly described here. The absolute configuration of patriscabratine was determined as (S,S). The compounds 1a-d and 2a-d have been tested by MTT assay in T47D, MDA-MB231, HL60, Hela and SGC-7901 cell lines in vitro. Among them, the (R,S) stereoisomer shows the strongest anticancer effects, while the (S,R) shows the weakest one. (C) 2009 Tie Min Sun. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
  • Synthesis and in vitro antitumor activity of asperphenamate derivatives as autophagy inducer
    作者:Lei Yuan、Yanchun Li、Chunyang Zou、Chao Wang、Jian Gao、Caixia Miao、Enlong Ma、Tiemin Sun
    DOI:10.1016/j.bmcl.2012.01.101
    日期:2012.3
    In an effort to improve the aqueous solubility and the antitumor activity of natural product asperphenamate, we have designed and synthesized three series of asperphenamate derivatives, including series I (simplifying molecular skeleton series), series II (introducing a hydroxyl group to A-phenyl ring series) and series III (disrupting molecular planarity series). All derivatives have displayed a significantly increased solubility compared with asperphenamate. Their growth inhibitory activities in vitro were screened by the standard MTT method in MCF-7, HeLa, and BEL-7402 cell lines. With the exception of the derivatives in series I, most of derivatives in series II and series III showed growth inhibitory activity. Among all derivatives, IM23b in series III showed the greatest potency in human breast cancer MCF-7 cells. The cellular potency of IM23b was approximately 1.5-fold more potent than that of cisplatin. The mechanism of cell death induced by IM23b in human breast cancer MCF-7 cells was further investigated. We concluded that the cell death was induced by autophagy instead of apoptosis or cell cycle arrest. (C) 2012 Elsevier Ltd. All rights reserved.
  • Banerji, Avijit; Ray, Rita, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1981, vol. 20, # 7, p. 597 - 598
    作者:Banerji, Avijit、Ray, Rita
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物